D Samuel

Summary

Country: France

Publications

  1. doi request reprint [Liver transplantation for chronic hepatitis B]
    D Samuel
    Assistance Publique Hopitaux de Paris, Hopital Paul Brousse, Centre Hepato Biliaire, Universite Paris Sud, UMR S 785, INSERM, Unite 785, 14, avenue P V Couturier, 94804, Villejuif, France
    Gastroenterol Clin Biol 32:S25-33. 2008
  2. doi request reprint The option of liver transplantation for hepatitis B: where are we?
    D Samuel
    INSERM, Unite 785, Villejuif, F 94804, France
    Dig Liver Dis 41:S185-9. 2009
  3. pmc Report of depressive symptoms on waiting list and mortality after liver and kidney transplantation: a prospective cohort study
    Emmanuelle Corruble
    INSERM U 669, Paris XI University, Psychiatry Department of Bicetre University Hospital, Assistance Publique Hopitaux de Paris, 94275 Le Kremlin Bicetre, France
    BMC Psychiatry 11:182. 2011
  4. ncbi request reprint [Liver transplantation]
    Didier Samuel
    Centre Hepatobiliaire, Universite Paris XI, 94800 Villejuif
    Rev Prat 57:280-6. 2007
  5. ncbi request reprint Domino liver transplantation from familial amyloidotic polyneuropathy donors: how close is the damocles sword to the recipient?
    Didier Samuel
    APHP, Centre Hepatobiliaire, Hopital Paul Brousse, Villejuif, France
    Transpl Int 20:921-3. 2007
  6. ncbi request reprint [Managing lamivudine resistance in liver transplantation for hepatitis B liver disease]
    Didier Samuel
    Centre Hepatobiliaire, INSERM U 785, Universite Paris Sud, Assistance Publique Hopitaux de Paris, 14 avenue Paul Vaillant Couturier, 94800 Villejuif, France
    Gastroenterol Clin Biol 30:3S26-30. 2006
  7. ncbi request reprint Report of the monothematic EASL conference on liver transplantation for viral hepatitis (Paris, France, January 12-14, 2006)
    Didier Samuel
    HepatoBiliary Centre, Inserm Paris XI U 785, Paul Brousse Hospital, APHP, Villejuif, France
    J Hepatol 45:127-43. 2006
  8. doi request reprint Toward optimizing the indications for orthotopic liver transplantation in hepatocellular carcinoma
    Didier Samuel
    Centre Hepato Biliaire, AP HP Hopital Paul Brousse, Villejuif, France
    Liver Transpl 17:S6-13. 2011
  9. doi request reprint Are HIV-infected patients candidates for liver transplantation?
    Didier Samuel
    INSERM U785, and Centre Hepato Biliare, AP HP Hopital Paul Brousse, Villejuif, France
    J Hepatol 48:697-707. 2008
  10. ncbi request reprint Residual hepatitis B virus particles in liver transplant recipients receiving lamivudine: PCR quantitation of HBV DNA and ELISA of preS1 antigen
    M A Petit
    INSERM E99 41 and UPRES 1596, Centre Hepato Biliaire, Villejuif, France
    J Med Virol 65:493-504. 2001

Detail Information

Publications91

  1. doi request reprint [Liver transplantation for chronic hepatitis B]
    D Samuel
    Assistance Publique Hopitaux de Paris, Hopital Paul Brousse, Centre Hepato Biliaire, Universite Paris Sud, UMR S 785, INSERM, Unite 785, 14, avenue P V Couturier, 94804, Villejuif, France
    Gastroenterol Clin Biol 32:S25-33. 2008
    ....
  2. doi request reprint The option of liver transplantation for hepatitis B: where are we?
    D Samuel
    INSERM, Unite 785, Villejuif, F 94804, France
    Dig Liver Dis 41:S185-9. 2009
    ..In conclusion, long-term prophylaxis should be maintained in most patients except those with anti-HBs seroconversion...
  3. pmc Report of depressive symptoms on waiting list and mortality after liver and kidney transplantation: a prospective cohort study
    Emmanuelle Corruble
    INSERM U 669, Paris XI University, Psychiatry Department of Bicetre University Hospital, Assistance Publique Hopitaux de Paris, 94275 Le Kremlin Bicetre, France
    BMC Psychiatry 11:182. 2011
    ..Our objective is to determine whether report of depressive symptoms on waiting list predicts outcome of liver and kidney transplantation...
  4. ncbi request reprint [Liver transplantation]
    Didier Samuel
    Centre Hepatobiliaire, Universite Paris XI, 94800 Villejuif
    Rev Prat 57:280-6. 2007
    ..In France, in 2007, the system of allocation organ will change (using a system similar to the MELD score) to prioritize patients with the highest risk of death while waiting for liver transplant...
  5. ncbi request reprint Domino liver transplantation from familial amyloidotic polyneuropathy donors: how close is the damocles sword to the recipient?
    Didier Samuel
    APHP, Centre Hepatobiliaire, Hopital Paul Brousse, Villejuif, France
    Transpl Int 20:921-3. 2007
  6. ncbi request reprint [Managing lamivudine resistance in liver transplantation for hepatitis B liver disease]
    Didier Samuel
    Centre Hepatobiliaire, INSERM U 785, Universite Paris Sud, Assistance Publique Hopitaux de Paris, 14 avenue Paul Vaillant Couturier, 94800 Villejuif, France
    Gastroenterol Clin Biol 30:3S26-30. 2006
  7. ncbi request reprint Report of the monothematic EASL conference on liver transplantation for viral hepatitis (Paris, France, January 12-14, 2006)
    Didier Samuel
    HepatoBiliary Centre, Inserm Paris XI U 785, Paul Brousse Hospital, APHP, Villejuif, France
    J Hepatol 45:127-43. 2006
  8. doi request reprint Toward optimizing the indications for orthotopic liver transplantation in hepatocellular carcinoma
    Didier Samuel
    Centre Hepato Biliaire, AP HP Hopital Paul Brousse, Villejuif, France
    Liver Transpl 17:S6-13. 2011
    ..8. On the basis of these considerations, a 5-year survival rate of 50% after liver transplantation for HCC seems too low...
  9. doi request reprint Are HIV-infected patients candidates for liver transplantation?
    Didier Samuel
    INSERM U785, and Centre Hepato Biliare, AP HP Hopital Paul Brousse, Villejuif, France
    J Hepatol 48:697-707. 2008
  10. ncbi request reprint Residual hepatitis B virus particles in liver transplant recipients receiving lamivudine: PCR quantitation of HBV DNA and ELISA of preS1 antigen
    M A Petit
    INSERM E99 41 and UPRES 1596, Centre Hepato Biliaire, Villejuif, France
    J Med Virol 65:493-504. 2001
    ..These findings confirm the persistence of HBV in liver transplant recipients despite strong inhibition of replication by lamivudine, and show abnormal viral transcription and/or morphogenesis in lamivudine-resistant patients...
  11. ncbi request reprint [Adult to adult living-related liver transplantation. The Paul-Brousse Hospital preliminary experience]
    D Azoulay
    Centre Hepato Biliaire, Hopital Paul Brousse, UPRES 1596, IFR 89 9, Universite Paris Sud, Villejuif, France
    Gastroenterol Clin Biol 25:773-80. 2001
    ..Follow-up ranged from 41 to 157 days (median: 117 days)...
  12. doi request reprint Fibrosing cholestatic hepatitis in HIV/HCV co-infected transplant patients-usefulness of early markers after liver transplantation
    T M Antonini
    AP HP Hopital Paul Brousse, Centre Hepato Biliaire, Villejuif, France
    Am J Transplant 11:1686-95. 2011
    ..004). An early diagnosis of FCH may be suggested by the presence of marked disease activity when acute hepatitis is diagnosed and when a high viral load is present. The initiation of anti-HCV therapy should be considered at this point...
  13. ncbi request reprint Successful tacrolimus therapy for a severe recurrence of type 1 autoimmune hepatitis in a liver graft recipient
    M Hurtova
    , , Villejuif, France
    Liver Transpl 7:556-8. 2001
    ..Tacrolimus therefore may be effective in patients with severe recurrent autoimmune liver disease. Further studies are needed to assess tacrolimus therapy in patients who fail to respond to standard immunosuppressive therapy...
  14. doi request reprint Progression of alphafetoprotein before liver transplantation for hepatocellular carcinoma in cirrhotic patients: a critical factor
    E Vibert
    AP HP, Hopital Paul Brousse, Centre Hepato Biliaire, INSERM, Unite 785, Universite Paris Sud, Villejuif, France
    Am J Transplant 10:129-37. 2010
    ..In conclusion, increasing AFP>15 microg/L/month while waiting for LT is the most relevant preoperative prognostic factor for low OS/DFS. AFP progression could be a pathological preoperative marker of tumor aggressiveness...
  15. ncbi request reprint Salvage transjugular intrahepatic portosystemic shunt for uncontrolled variceal bleeding in patients with decompensated cirrhosis
    D Azoulay
    Department of Liver Surgery and Liver Transplantation, Centre Hepato Biliaire, UPRES No 1596, IFR 89 9, Hopital Paul Brousse, Villejuif, France
    J Hepatol 35:590-7. 2001
    ..To investigate the outcome of early salvage TIPS for active uncontrolled variceal haemorrhage, and to identify the factors associated with mortality...
  16. doi request reprint Short- and long-term donor morbidity in right lobe living donor liver transplantation: 91 consecutive cases in a European Center
    D Azoulay
    AP HP Hopital Paul Brousse, Centre Hepato Biliaire, Villejuif, France
    Am J Transplant 11:101-10. 2011
    ..50%; p = 0.06). In the long term, donors expressed an overall sense of well being, but some sequelae of surgery do restrain their current lifestyle. Our results warn against lackadaisical vigilance once RLLD hepatectomy becomes routine...
  17. doi request reprint Non-invasive ICG-clearance: a useful tool for the management of hepatic artery thrombosis following liver transplantation
    E Levesque
    AP HP Hopital Paul Brousse, Centre Hepato Biliaire, Villejuif, France
    Clin Transplant 25:297-301. 2011
    ..Thus, we evaluated the role of PDR-ICG measurement in HAT diagnosis in post-LT patients...
  18. ncbi request reprint Detection of gammopathy by serum protein electrophoresis for predicting and managing therapy of lymphoproliferative disorder in 911 recipients of liver transplants
    A Lemoine
    Service de Biochimie et Biologie Moléculaire, Hopital Paul Brousse, Faculté de Médecine Paris Sud et Assistance Publique de Paris, Villejuif, France
    Blood 98:1332-8. 2001
    ..Gammopathy monitoring is an inexpensive, noninvasive, sensitive way to detect LPD and assess the efficacy of treatment. It could be used routinely in follow-up of recipients of transplants...
  19. ncbi request reprint [Combined transplantation of liver and small intestine in an adult. First case in France. Surgical aspects]
    D Azoulay
    Centre Hepato Biliaire, Hopital Paul Brousse, Villejuif, Universite Paris Sud
    Presse Med 28:2211-3. 1999
    ..We report hare the first adult case of combined liver-small bowel transplantation performed in France...
  20. ncbi request reprint Primary non-Hodgkin's lymphomas of the liver with nodular and diffuse infiltration patterns have different prognoses
    J F Emile
    Service d Anatomie Pathologique, Hopital Paul Brousse, UPRES 1596 and IFR 89, Universite Paris Sud, France
    Ann Oncol 12:1005-10. 2001
    ..Primary liver non-Hodgkin's lymphomas have peculiar clinical and biological patterns. This study correlates these patterns with pathology and outcome...
  21. ncbi request reprint "Silent" presentation of veno-occlusive disease after liver transplantation as part of the process of cellular rejection with endothelial predilection
    M Sebagh
    Service d Anatomie Pathologique, Hopital Paul Brousse, Villejuif, UPRES virus hépatotropes et cancers, Universite Paris Sud, France
    Hepatology 30:1144-50. 1999
    ..In conclusion, the incidence of VOD was 1.9% after OLT. The association of prominent endothelial involvement and VOD with acute rejection in most cases suggests an immunological phenomenon...
  22. doi request reprint Persistence of yellow fever vaccine-induced antibodies after solid organ transplantation
    B Wyplosz
    Assistance Publique Hopitaux de Paris, CHU Bicetre, Service de Maladies Infectieuses et Tropicales, Centre de Vaccinations Internationales, Paris, Le Kremlin Bicetre, France
    Am J Transplant 13:2458-61. 2013
    ..Our data suggest there is long-term persistence of antibodies to yellow fever in SOT recipients who have been vaccinated prior to transplantation...
  23. ncbi request reprint Reversibility of acquired amyloid polyneuropathy after liver retransplantation
    T M Antonini
    AP HP, Hopital Paul Brousse, Centre Hepato Biliaire, Villejuif, France Univ Paris Sud, UMR S 785, Villejuif, France INSERM, Unite 785, Villejuif, France French National Reference Centre for FAP NNERF, Le Kremlin Bicetre, F 94275, France
    Am J Transplant 13:2734-8. 2013
    ..His clinical and paraclinical improvement is described, and the impact of this case on the indication for a domino procedure and the challenges linked to retransplantation are discussed...
  24. ncbi request reprint [Liver transplantation: is it possible in HIV/HCV co-infected patients?]
    D Vittecoq
    Service des Maladies Infectieuses, Hopital Paul Brousse, 12 14, avenue Paul Vaillant Couturier, 94800 Villejuif, France
    Pathol Biol (Paris) 51:525-7. 2003
    ..Finally, liver transplantation in HIV-HCV co-infected patients seems to be feasible when strict criteria of selection are taken into account. This still experimental strategy requires a multidisciplinary partnership...
  25. ncbi request reprint [Autoimmune hepatitis. Physiopathologic, clinical, histological, and therapeutic features]
    J C Duclos-Vallee
    Centre Hepato Biliaire, EPI 99 41 et UPRES 1596, Hopital Paul Brousse, 14, avenue Paul Vaillant Couturier, 94804 Villejuif
    Ann Med Interne (Paris) 152:371-82. 2001
    ..If relapse or non response occur, other immunosuppressive therapy such as cyclosporin may be useful. Liver transplantation is reserved for (sub)fulminant forms and end stage liver disease...
  26. ncbi request reprint Liver transplantation in Italy. Letter to Italian friends
    D Samuel
    Centre Hepatobiliaire, Hĵpital Paul Brousse Assistance Publique Hĵpitaux de Paris, Faculte de Medecine Paris Sud, UPRES 1596, Villejuif, France
    Dig Liver Dis 34:619-20. 2002
  27. ncbi request reprint Risk factors for hepatitis C recurrence after liver transplantation
    B Roche
    Assistance Publique Hopitaux de Paris, Hopital Paul Brousse, Centre Hépato Biliaire and INSERM, Unité 785 and Université Paris Sud, UMR S 785, Villejuif, France
    J Viral Hepat 14:89-96. 2007
    ..Cautious follow-up of the pathology of the graft is mandatory including routine biopsies and / or noninvasive monitoring of fibrosis...
  28. doi request reprint Human herpesvirus 8 (HHV8) transmission and related morbidity in organ recipients
    C Lebbe
    Assistance Publique Hopitaux de Paris, Department of Dermatology, Universite Paris Diderot, INSERM U, Hopital Saint Louis, France
    Am J Transplant 13:207-13. 2013
    ..Donor screening is advisable for monitoring HHV8 seronegative liver transplant recipients...
  29. pmc Auxiliary partial orthotopic versus standard orthotopic whole liver transplantation for acute liver failure: a reappraisal from a single center by a case-control study
    D Azoulay
    Hepatobiliary Surgery and Liver Transplant Unit, UPRES 1596, IFR 89 9, Hopital Paul Brousse, Universite Paris Sud, 94804 Villejuif, France
    Ann Surg 234:723-31. 2001
    ..To reappraise the results of auxiliary partial orthotopic liver transplantation (APOLT) compared with those of standard whole-liver transplantation (OLT) in terms of postoperative death and complications, including neurologic sequelae...
  30. pmc Antibodies to hepatitis B surface antigen prevent viral reactivation in recipients of liver grafts from anti-HBC positive donors
    A M Roque-Afonso
    Laboratoire de Virologie, Hopital Paul Brousse, Université Paris Sud UPRES 1596, 12 avenue Paul Vaillant Couturier, 94804 Villejuif, France
    Gut 50:95-9. 2002
    ....
  31. doi request reprint [Hepatic transplantation]
    C Duvoux
    Service d Hépatologie de Gastroentérologie, Hopital Henri Mondor, Assistance Publique Hopitaux de Paris, Universite Paris 12, 94010 Creteil Cedex, France
    Gastroenterol Clin Biol 33:868-81. 2009
    ....
  32. pmc A 10 year follow up study of patients transplanted for autoimmune hepatitis: histological recurrence precedes clinical and biochemical recurrence
    J C Duclos-Vallee
    Centre Hepato Biliaire, EPI 99 41 et UPRES 1596, Hopital Paul Brousse, Villejuif, France
    Gut 52:893-7. 2003
    ..The aim of the present study was to examine the clinical and histological outcome more than 10 years after OLT for AIH...
  33. ncbi request reprint [Liver transplantation in patients co-infected with HIV]
    D Samuel
    Centre Hepatobiliaire, EA 3541, Hopital Paul Brousse, 12, avenue Paul Vaillant Couturier, 94800 Villejuif, France
    Med Mal Infect 34:9-11. 2004
  34. pmc Rapid multifocal chondrolysis after liver transplantation in four patients
    J Taillandier
    Service de Gérontologie et Réadaptation Fonctionnelle, Hopital Paul Brousse, Assistance Publique Hopitaux de Paris AP HP, Villejuif, France
    Ann Rheum Dis 65:118-20. 2006
    ..Case report: A previously unreported joint complication in liver transplant recipients is described...
  35. doi request reprint [Vaccinations for the traveling adult solid organ transplant recipient (excluding hematopoietic stem cell transplant recipients)]
    B Wyplosz
    Unité de maladies infectieuses et tropicales, Hôpital Universitaire Paul Brousse, Assistance Publique Hopitaux de Paris, Faculte de Medecine, Universite Paris Sud 11, 12 14, 94804 Villejuif Cedex, France
    Med Mal Infect 39:225-33. 2009
    ..In this comprehensive review, we provide vaccination schedules based on published studies and guidelines for vaccination of solid organ transplant recipients...
  36. ncbi request reprint [Liver transplantation for patients infected with both HIV and HCV or HIV and HBV]
    Jean Charles Duclos-Vallée
    Département des Maladies du Foie et INSERM U785, Unité de maladies infectieuses, Universite Paris XI, Centre Hepato Biliaire, Hopital Paul Brousse, 12 14, avenue Paul Vaillant Couturier, 94804, Villejuif, France
    Med Sci (Paris) 23:723-8. 2007
    ..Understanding HCV recurrence mechanisms, and preventing and treating of HCV recurrence are major future challenges...
  37. doi request reprint Identification of plasma membrane autoantigens in autoimmune hepatitis type 1 using a proteomics tool
    Fatima Tahiri
    INSERM, Unite 785, Villejuif F 94800, France
    Hepatology 47:937-48. 2008
    ..The presence of anti-membrane antibodies was confirmed by immunofluorescence and immunoelectron microscopy...
  38. ncbi request reprint Viral and clinical factors associated with surface gene variants among hepatitis B virus carriers
    Anne Marie Roque-Afonso
    INSERM U785, 94804 Villejuif, France
    Antivir Ther 12:1255-63. 2007
    ..We focused on variations in the major hydrophilic region (MHR), the central core of HBsAg known to be exposed on the surface and involved in antibody binding...
  39. ncbi request reprint Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus
    Jean Charles Duclos-Vallée
    Centre Hepato Biliaire, AP HP Hopital Paul Brousse, Villejuif, France
    Hepatology 47:407-17. 2008
    ..03; risk ratio, 1.08; 95% confidence interval, 1.01, 1.15). Using the Kaplan-Meier method, the progression to fibrosis >or= F2 was significantly higher in the coinfected group (P < 0.0001)...
  40. ncbi request reprint HBV DNA persistence 10 years after liver transplantation despite successful anti-HBS passive immunoprophylaxis
    Bruno Roche
    Centre Hepato Biliaire, Hopital Paul Brousse, Villejuif, France
    Hepatology 38:86-95. 2003
    ..Combination prophylaxis with HBIG and antiviral therapy is effective in patients with viral replication. Although there were only a few cases of HBV recurrence after 5 years, HBV DNA remained present in 45% of patients at 10 years...
  41. ncbi request reprint Distinct hepatitis C virus core and F protein quasispecies in tumoral and nontumoral hepatocytes isolated via microdissection
    Rodolphe Sobesky
    Institut National de la Sante et de la Recherche Medicale INSERM, U785, Villejuif, France
    Hepatology 46:1704-12. 2007
    ..Our study supports the importance of core genetic variability in hepatocellular carcinogenesis...
  42. ncbi request reprint Immunosuppression in hepatitis B virus and hepatitis C virus transplants: special considerations
    Didier Samuel
    Centre Hepato Biliaire, Hopital Paul Brousse, Universite Paris Sud, 12 14 avenue Paul Vaillant Couturier, 94800 Villejuif, France UPRES 3541
    Clin Liver Dis 7:667-81. 2003
    ..It will allow adapting the effectiveness of the immunosuppression treatment. The treatment's primary target is to avoid graft rejection, and its secondary objective is to limit the risk of viral recurrence...
  43. ncbi request reprint Effect of highly active antiretroviral therapy on tacrolimus pharmacokinetics in hepatitis C virus and HIV co-infected liver transplant recipients in the ANRS HC-08 study
    Elina Teicher
    Internal Medicine and Infectious Diseases Department, Hopital Paul Brousse, Assistance Publique Hopitaux de Paris AP HP, Paris, France
    Clin Pharmacokinet 46:941-52. 2007
    ..To characterise the interactions between tacrolimus and antiretroviral drug combinations in hepatitis C virus-HIV co-infected patients who had received a liver transplant...
  44. ncbi request reprint Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre- and post-liver transplantation patients
    Eugene R Schiff
    Center for Liver Diseases, University of Miami, Miami, FL 33136, USA
    Hepatology 38:1419-27. 2003
    ..In conclusion, 48 weeks of adefovir dipivoxil resulted in significant improvements in virologic, biochemical, and clinical parameters in CHB patients pre- and post-LT with lamivudine-resistant HBV...
  45. ncbi request reprint Identification by proteomic tool of atypical anti-liver/kidney microsome autoantibodies targets in de novo autoimmune hepatitis after liver transplantation
    Stéphanie Huguet
    INSERM, Unite 785, Villejuif, F 94804, France
    Ann N Y Acad Sci 1109:345-57. 2007
    ..These results could lead to a better diagnosis of this disease using identified autoantigens in diagnostic tests, and strengthen proteomic approach as a new way of autoantigens investigation...
  46. ncbi request reprint A decision analysis model identifies the interval of efficacy for transarterial chemoembolization (TACE) in cirrhotic patients with hepatocellular carcinoma awaiting liver transplantation
    Thomas A Aloia
    Division of Abdominal Transplantation and Hepatobiliary Surgery, Department of Surgery, Baylor College of Medicine, 1709 Dryden, Suite 15 37, Houston, TX 77030, USA
    J Gastrointest Surg 11:1328-32. 2007
    ..The objective of our study was to determine if there was a specific time interval where neoadjuvant TACE would decrease the number of HCC patients removed from the pretransplant waitlist...
  47. ncbi request reprint New sensitive tools for hepatitis B virus (HBV) detection in liver transplantation: what will be their impact on the prophylaxis of HBV infection?
    Didier Samuel
    Liver Transpl 13:1084-7. 2007
  48. ncbi request reprint Long-term effects of calcineurin inhibitor conversion to mycophenolate mofetil on renal function after liver transplantation
    Caroline Creput
    Nephrology and Transplantation Unit, Kremlin Bicetre Hospital, Kremlin Bicêtre France
    Liver Transpl 13:1004-10. 2007
    ..In liver recipients with CRF, a reduction or withdrawal of CNI concomitantly with the introduction of MMF was safe and was associated with an improvement in renal function...
  49. ncbi request reprint [Liver transplantation in patients with HIV: indications, limits, perspectives]
    Didier Samuel
    Centre Hepatobiliaire, UPRES 3541, Formation Associée de Recherche Association Claude Bernard Virus et Transplantation, Universite Paris Sud
    Gastroenterol Clin Biol 27:372-4. 2003
  50. ncbi request reprint Hepatocellular carcinoma is associated with an increased risk of hepatitis B virus recurrence after liver transplantation
    Luciana C Faria
    INSERM, U 785, Villejuif, France
    Gastroenterology 134:1890-9; quiz 2155. 2008
    ..The role of hepatocellular carcinoma (HCC) in HBV recurrence remains unclear. We investigated the association between HCC pre-OLT and HBV recurrence post-OLT...
  51. ncbi request reprint Accuracy of bile duct changes for the diagnosis of chronic liver allograft rejection: reliability of the 1999 Banff schema
    Mylene Sebagh
    Service d Anatomie Pathologique, Centre Hepato Biliaire, and Unité de Santé Publique, Hopital Paul Brousse, Villejuif, France
    Hepatology 35:117-25. 2002
    ..However, limited information can be drawn regarding the outcome of CR based on histology alone. Transient lobular hepatitis, unrelated to viral infection and veno-occlusive disease, may be an unusual expression of CR...
  52. ncbi request reprint [Prevention and treatment of hepatitis B virus infection after liver transplantation]
    Bruno Roche
    Centre Hepatobiliaire, Hopital Paul Brousse, 14 avenue Paul Vaillant Couturier, 94800 Villejuif, France
    Gastroenterol Clin Biol 26:271-83. 2002
  53. ncbi request reprint [Natural history, prevention and treatment of hepatitis C virus after liver transplantation]
    Bruno Roche
    Centre Hepatobiliaire, Hopital Paul Brousse, 14, avenue Paul Vaillant Couturier, 94800 Villejuif, France
    Gastroenterol Clin Biol 26:331-9. 2002
  54. ncbi request reprint [HBV cirrhosis]
    Didier Samuel
    Centre Hepato Biliaire, Hopital Paul Brousse, 14, avenue Paul Vaillant Couturier, 94800 Villejuif, France
    Gastroenterol Clin Biol 26:514-7. 2002
  55. ncbi request reprint [Pneumocystis carinii and cytomegalovirus pneumonia after corticosteroid therapy in acute severe alcoholic hepatitis: 2 case reports]
    Philippe Ichai
    Centre Hepato Biliaire, Hopital Paul Brousse, UPRES 1596, Universite Paris Sud, Villejuif, France
    Gastroenterol Clin Biol 26:532-4. 2002
    ..In conclusion, Pneumocystis carinii pneumonia is a potential complication of steroid treatments for acute alcoholic hepatitis and should be suspected in case of unexplained pulmonary infection...
  56. ncbi request reprint [Treatment of hepatitis C after liver transplantation]
    Didier Samuel
    Centre Hepatobiliaire, Hopital Paul Brousse, Villejuif
    Gastroenterol Clin Biol 26:B231-7. 2002
  57. ncbi request reprint I favor therapy for hepatitis C virus recurrence after transplantation
    Didier Samuel
    Centre Hepatobiliaire, Hôpital Paul Brousse Assistance Publique Hôpitaux de Paris, Faculte de Medecine Paris Sud, UPRES 1596, EPI 99 41, Villejuif, France
    Liver Transpl 8:S55-8. 2002
  58. ncbi request reprint [The bioartificial liver: hopes and realities]
    Didier Samuel
    Gastroenterol Clin Biol 26:721-3. 2002
  59. pmc Decision for retransplantation of the liver: an experience- and cost-based analysis
    Daniel Azoulay
    Hepatobiliary Center, Hospital Paul Brousse, Assitance Publique Hôpitaux de Paris and Université Paris Sud, Villejuif, France
    Ann Surg 236:713-21; discussion 721. 2002
    ..To determine the patient factors affecting patient outcome of first liver retransplantation at a single center to help in the decision process for retransplantation...
  60. ncbi request reprint Adoptive transfer of immunity to HBV through liver graft: does it prevent HBV recurrence?
    Didier Samuel
    Hepatology 37:16-8. 2003
  61. ncbi request reprint [Prevention and treatment of hepatitis B virus infection after liver transplantation]
    Bruno Roche
    Centre Hepatobiliaire, EA 3541, Universite Paris Sud, Villejuif, France
    Gastroenterol Clin Biol 29:393-404. 2005
  62. ncbi request reprint Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study
    Didier Samuel
    Centre Hepatobiliaire, Hôpital Paul Brousse Assistance Publique Hôpitaux de Paris, Faculte de Medecine Paris Sud, EA 3541, EPI 99 41 et Association Claude Bernard, Villejuif, France
    Gastroenterology 124:642-50. 2003
    ..The use of antiviral therapy in this situation remains controversial. This study aimed to assess the safety and efficacy of interferon alfa-2b plus ribavirin for recurrent hepatitis C following liver transplantation...
  63. ncbi request reprint Quality of life in adult survivors beyond 10 years after liver, kidney, and heart transplantation
    Vincent H Karam
    Centre Hepato Biliaire, Hopital Paul Brousse, 4 Avenue Paul Vaillant Couturier, 94804 Villejuif Cedex, France
    Transplantation 76:1699-704. 2003
    ..The yearly increasing survival rates testify to the success of transplantation, but questions remain relating to the quality of life (QOL) associated with long-term survival...
  64. ncbi request reprint Ribavirin in the treatment of recurrent hepatitis C after liver transplantation: difficult to manage but essential for success
    Didier Samuel
    J Hepatol 46:988-91. 2007
  65. ncbi request reprint Management of the hepatitis B virus in the liver transplantation setting: a European and an American perspective
    Norah Terrault
    University of California at San Francisco, San Francisco, CA, USA
    Liver Transpl 11:716-32. 2005
  66. ncbi request reprint Male cell microchimerism in normal and diseased female livers from fetal life to adulthood
    Catherine Guettier
    Service d Anatomie Pathologique, Unité propre de recherche de l enseignement supérieur UPRES N degree 3541, Universite Paris XI, Hopital Paul Brousse, Villejuif, France
    Hepatology 42:35-43. 2005
    ....
  67. ncbi request reprint Changes in renal function in patients with familial amyloid polyneuropathy treated with orthotopic liver transplantation
    Renaud Snanoudj
    Service de Nephrologie, Hémodialyse et Transplantation, Villejuif, France
    Nephrol Dial Transplant 19:1779-85. 2004
    ..Orthotopic liver transplantation (OLT) has been proposed to prevent disease progression. Little is known about long-term changes in renal function and lesions after OLT...
  68. ncbi request reprint Management of hepatitis B in liver transplantation patients
    Didier Samuel
    Centre Hepatobiliaire, Universite Paris Sud, Hopital Paul Brousse, Assistance Publique Hopitaux de Paris, Villejuif, France
    Semin Liver Dis 24:55-62. 2004
    ..HBIg therapy may be discontinued in selected patients after transplantation, albeit with caution, because low levels of HBV DNA have persisted. Antiviral therapy has improved the prognosis after graft infection...
  69. ncbi request reprint Antiviral treatment of recurrent hepatitis C after liver transplantation: the need for a multifaceted approach
    Didier Samuel
    Hepatology 41:436-8. 2005
  70. ncbi request reprint Hepatitis C virus viral recurrence and liver mitochondrial damage after liver transplantation in HIV-HCV co-infected patients
    Jean Charles Duclos-Vallée
    Centre Hépato Biliaire Hôpital Paul Brousse, Assistance Publique Hopitaux de Paris, 94804 Villejuif, France
    J Hepatol 42:341-9. 2005
    ..We report the Paul Brousse Hospital experience of transplantation for end stage cirrhosis in HIV-HCV co-infected patients...
  71. ncbi request reprint Treatment of hepatitis B and C after liver transplantation. Part 1, hepatitis B
    Bruno Roche
    Centre Hepatobiliaire, UPRES 3541, EPI 99 41, Universite Paris Sud, Hopital Paul Brousse, 14 Ave P V Couturier, 94800 Villejuif, France
    Transpl Int 17:746-58. 2005
    ..Several antiviral drugs have been developed for the management of HBV infection on the graft, so outcome is currently good...
  72. ncbi request reprint Place of the liver biopsy in liver transplantation
    Mylene Sebagh
    Laboratoire d anatomopathologie, Centre Hepatobiliaire, Hopital Paul Brousse, 14 avenue Paul Vaillant Couturier, 94800 Villejuif, France
    J Hepatol 41:897-901. 2004
  73. ncbi request reprint Steroid withdrawal at day 14 after liver transplantation: a double-blind, placebo-controlled study
    Georges Philippe Pageaux
    CHU St Eloi, Montpellier, France
    Liver Transpl 10:1454-60. 2004
    ..10). In conclusion, this first double-blind, placebo-controlled study of steroid withdrawal at day 14 showed a higher incidence of acute rejection, only balanced by a trend of a lower need of antidiabetic treatment...
  74. ncbi request reprint Evolving strategies to prevent HBV recurrence
    Bruno Roche
    Centre Hepatobiliaire, Hopital Paul Brousse, Villejuif, France
    Liver Transpl 10:S74-85. 2004
    ....
  75. ncbi request reprint Donor age influences 10-year liver graft histology independently of hepatitis C virus infection
    Kinan Rifai
    Centre Hepato Biliaire, Hopital Paul Brousse, Villejuif Assistance Publique Hôpitaux de Paris, Universite Paris Sud, 12 14 avenue Paul Vaillant Couturier, 94800 Villejuif, France
    J Hepatol 41:446-53. 2004
    ..Factors influencing the long-term histological outcome of liver graft are not known. We conducted a prospective study based on a 10-year liver biopsy in order to identify the main factors influencing long-term graft histology...
  76. ncbi request reprint Hepatitis C, interferon, and risk of rejection after liver transplantation
    Didier Samuel
    Liver Transpl 10:868-71. 2004
  77. ncbi request reprint The questionable role of immunization against hepatitis B in HBV infected liver transplant patients
    Didier Samuel
    J Hepatol 43:203-6. 2005
  78. ncbi request reprint Could post-liver transplantation course be helpful for the diagnosis of so called cryptogenic cirrhosis?
    Jean Charles Duclos-Vallée
    Centre Hepato Biliaire, Hopital Paul Brousse, Assistance Publique Hopitaux de Paris, Villejuif, France
    Clin Transplant 19:591-9. 2005
    ..In all cases a precise diagnosis is obviously of practical interest for better management of post-transplant survey and treatment...
  79. ncbi request reprint Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis
    Philippe Ichai
    Centre Hépatobiliaire and INSERM Unit 785, Assistance Publique Hopitaux de Paris, Universite Paris Sud, Hopital Paul Brousse, Villejuif, France
    Liver Transpl 13:996-1003. 2007
    ..Among the untreated patients, 3 survived after LT and 1 died without LT. In conclusion, corticosteroid therapy is of little benefit in severe and fulminant forms of AIH; it may favor septic complications and should not delay LT...
  80. ncbi request reprint Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: final long-term results
    Eugene Schiff
    Center for Liver Diseases, University of Miami, Miami, FL 33136, USA
    Liver Transpl 13:349-60. 2007
    ..In conclusion, adefovir dipivoxil is effective and safe in wait-listed or posttransplantation CHB patients with lamivudine-resistant HBV and prevents graft reinfection with or without HBIg...
  81. ncbi request reprint Liver transplantation for hepatitis B virus-related liver disease: indications, prevention of recurrence and results
    Bruno Roche
    Centre Hépatobiliary, UPRES 3541, Formation de recherche Claude Bernard Virus et Transplantation, Universite Paris Sud, Hopital Paul Brousse, Assistance Publique Hopitaux de Paris, 14 avenue Paul Vaillant Couturier, 94800 Villejuif, France
    J Hepatol 39:S181-9. 2003
  82. ncbi request reprint 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus
    Gary Levy
    University Health Network, Toronto General Hospital, Toronto, ON, Canada
    Liver Transpl 12:1464-72. 2006
    ..More patients required antidiabetic therapy with tacrolimus regardless of diabetic status at baseline...
  83. ncbi request reprint Solitary pulmonary metastasis arising thirteen years after liver transplantation for HBV-related hepatocellular carcinoma
    Chiara Viola
    Service d Hepatologie, INSERM CRB3, University of Paris VII, Hopital, Beaujon, Clichy 92 110, France
    World J Gastroenterol 12:4911-3. 2006
    ..Many HCCs grow slowly, and the growth rate of recurrent tumors in patients receiving immunosuppressive therapy is significantly greater than that of those who do not receive immunosuppressive therapy...
  84. ncbi request reprint Characteristics of patients with chronic hepatitis B in France: predominant frequency of HBe antigen negative cases
    Jean Pierre Zarski
    Département d Hépato Gastroentérologie, CHU de Grenoble BP 217 38043 Grenoble CEDEX 9, France
    J Hepatol 45:355-60. 2006
    ..The aim of this study was to analyze the frequency and the characteristics of HBeAg-negative as compared with HBeAg-positive chronic hepatitis B in France...
  85. ncbi request reprint The MTHFR 677C > T polymorphism is associated with an increased risk of hepatocellular carcinoma in patients with alcoholic cirrhosis
    Raphael Saffroy
    Service de Biochimie et Biologie Moléculaire, Cedex, France
    Carcinogenesis 25:1443-8. 2004
    ..02). The relative risk for HCC in subjects with alcoholic cirrhosis and the CC genotype was 2.03. These results suggest that the MTHFR CC genotype increases the risk to develop HCC in patients who consume a high alcohol diet...
  86. ncbi request reprint The difficulty in timing for liver transplantation in cirrhotic patients coinfected with HIV: in search for a prognosis score
    Didier Samuel
    Liver Transpl 12:699-701. 2006
  87. ncbi request reprint Medical community preferences concerning adult living related donor liver transplantation
    Denis Castaing
    Centre Hepato Biliaire, Hopital Paul Brousse, UPRES 1596, Universite Paris Sud, Villejuif
    Gastroenterol Clin Biol 30:183-7. 2006
    ..To assess acceptance and acceptable estimated mortality levels for right lobe adult-to-adult living related liver transplantation for the medical and allied professions...
  88. ncbi request reprint Aspects of hepatitis C virus infection relating to liver transplantation
    Bruno Roche
    Centre Hepatobiliaire, Hopital Paul Brousse, Villejuif, France
    Eur J Gastroenterol Hepatol 18:313-20. 2006
    ..Combination therapy gave promising results, with sustained virological response in 25-35% of patients, but indications, modality and duration of treatment should be assessed...
  89. ncbi request reprint [Liver transplantation for complications of hepatitis B]
    Bruno Roche
    Centre Hepatobiliaire, Hopital Paul Brousse, Villejuif
    Presse Med 35:335-45. 2006
    ..If there was no detectable viral load pre-graft, withdrawal of HBIG should be considered at some point, while continuing an antiviral agent or after anti-HBV vaccination...
  90. ncbi request reprint [Liver transplantation]
    Elisabeth Kimmoun
    Unité d Hépatologie, centre hépato billiaire, Hopital Paul Brousse, Villejuif
    Rev Prat 54:15-6. 2004
  91. ncbi request reprint Results of lis2t, a multicenter, randomized study comparing cyclosporine microemulsion with C2 monitoring and tacrolimus with C0 monitoring in de novo liver transplantation
    Gary Levy
    University Health Network, The Toronto Hospital, Toronto, Canada
    Transplantation 77:1632-8. 2004
    ..The incidence of adverse events is comparable except for a significantly higher incidence of diabetes mellitus and diarrhea in the tacrolimus group. Both agents are effective primary immunosuppressants in liver transplant recipients...